FIELD: medicine.
SUBSTANCE: method of local therapy of osteoarthritis of the knee joint including the initial five intra-articular (IA) injections of 2 ml, while the interval between the first and second IA injections is 2 days, between the second and subsequent injections is 3 days, and subsequent sixteen intramuscular (IM) injections of 2 ml with an interval of 1 day, where the interval between the last IA and the first IM injection is 2 days, to a patient in need of a medicinal product containing chondroitin sulfate sodium, sodium disulfite, methyl parahydroxybenzoate, 1 M sodium hydroxide solution and water for injection in the following ratio of components, per 1 ml of the preparation: active ingredient: 100 mg of sodium chondroitin sulfate (in terms of dry matter); excipients: 2 mg of sodium disulfite; 0.5 mg of methyl parahydroxybenzoate; 1 M sodium hydroxide solution with pH 6.0÷7.5; up to 1.0 ml of water for injection.
EFFECT: above method allows to increase the effectiveness of therapy for osteoarthritis of the knee in patients who need it, to reduce the severity of gonarthrosis.
1 cl, 8 tbl
Title | Year | Author | Number |
---|---|---|---|
COMBINED AGENT FOR TREATING ARTHROLOGICAL DISEASES | 2024 |
|
RU2827069C1 |
AGENT FOR TREATING ARTHROLOGICAL DISEASES IN LYOPHILIZED FORM FOR INJECTIONS | 2024 |
|
RU2827073C1 |
METHOD FOR TREATMENT OF JOINT DISEASES | 2021 |
|
RU2777213C1 |
AGENT FOR TREATING DEGENERATIVE PROCESSES OF MUSCULOSKELETAL SYSTEM | 2024 |
|
RU2827071C1 |
CHONDROITIN SULFATE SOLUTION FOR INTRAMUSCULAR ADMINISTRATION AND METHOD FOR ITS PREPARATION | 2015 |
|
RU2623050C2 |
PREPARATION WITH CHONDROPROTECTIVE AND ANTI-INFLAMMATORY EFFECT | 2024 |
|
RU2832653C1 |
STABLE TREATMENT FOR JOINTS DISEASES | 2018 |
|
RU2680804C1 |
LYOPHILISED PHARMACEUTICAL COMPOSITION FOR PREPARING SOLUTION FOR INJECTIONS FOR TREATING DEGENERATE-DYSTROPHIC LOCOMOTOR DISEASES AND METHOD FOR PREPARING IT | 2011 |
|
RU2458693C1 |
PREPARATION FOR SYMPTOMATIC TREATMENT OF LOCOMOTOR APPARATUS DISEASES AND PREPARATION METHOD THEREOF | 2016 |
|
RU2614958C1 |
PHARMACEUTICAL AGENT FOR TREATING ARTHROLOGICAL DISEASES | 2024 |
|
RU2835423C1 |
Authors
Dates
2023-07-24—Published
2022-09-06—Filed